MATERIAL EVENT4527.TTSE

Rohto Pharmaceutical: securities issuance

Summary

ROHTO PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2025-02-26 16:00 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100VAZD ↗ · PDL1.0 · Not investment advice